---
type: "NewsArticle"
title: "Recognition-memory changes tracked progression in an early Alzheimer’s cohort"
description: "A 24-month study of 278 older adults with amnestic mild cognitive impairment found that lower recognition discriminability and early decline predicted conversion to Alzheimer’s dementia after adjustment for other measures."
resource: "https://nootropikler.com/news/alzheimer-recognition-memory-progression-cohort"
tags: ["research", "brain", "cognition"]
timestamp: 2026-10-05T14:45:25Z
language: "en"
---

# Recognition-memory changes tracked progression in an early Alzheimer’s cohort

A 24-month study of 278 older adults with amnestic mild cognitive impairment found that lower recognition discriminability and early decline predicted conversion to Alzheimer’s dementia after adjustment for other measures.

Author: Nootropik News Editorial Team
Published: 2026-10-05T14:45:25Z
Update: 2026-10-05T14:45:25Z
News/source date: 2026-09-16
Production: AI-assisted sourced summary and translation; no independent medical expert review is claimed.

## Study design

The prospective cohort followed 278 older adults with amnestic mild cognitive impairment for 24 months. Researchers assessed verbal learning and separated recognition hits from false alarms to calculate d-prime; a subset also had cerebrospinal-fluid or imaging biomarkers.

## What the study found

Delayed recall, recognition hits, and d-prime declined over time, with steeper changes among participants who later converted to Alzheimer’s dementia. Lower baseline d-prime and a larger early decline predicted conversion after adjustment for demographic factors, global cognition, and Alzheimer’s biomarkers.

## Limits and interpretation

This observational cohort supports a prognostic association, not proof that recognition-memory change causes progression. Biomarkers were available only in a subset, and the study does not establish a stand-alone screening threshold or show that acting on the measure improves outcomes.

## Sources

- [Recognition memory as a neuropsychological marker of progression in early-stage Alzheimer's disease: a 24-month prospective cohort study](https://doi.org/10.1080/13803395.2026.2732062) — 2026-09-16
